Related references
Note: Only part of the references are listed.Racial and Socioeconomic Disparities in Pediatric Type 1 Diabetes: Time for a Paradigm Shift in Approach
Terri H. Lipman et al.
DIABETES CARE (2021)
Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
Thomas B. Kjeldsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Strategies for durable β cell replacement in type 1 diabetes
Todd M. Brusko et al.
SCIENCE (2021)
Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation
Bruce A. Perkins et al.
SCIENCE (2021)
The Evolution of Insulin and How it Informs Therapy and Treatment Choices
Irl B. Hirsch et al.
ENDOCRINE REVIEWS (2020)
Review: Glucose-sensitive insulin
Thomas Hoeg-Jensen
MOLECULAR METABOLISM (2020)
Glycemic Status Assessment by the Latest Glucose Monitoring Technologies
Ilaria Malandrucco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes
Thomas Danne et al.
PEDIATRIC DIABETES (2018)
Dorothy Hodgkin Lecture 2013* Artificial Pancreas Project at Cambridge 2013
R. Hovorka
DIABETIC MEDICINE (2015)
Hepatoselectivity and the evolution of insulin
R. Herring et al.
DIABETES OBESITY & METABOLISM (2014)
Diabetes Mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types
H. P. Himsworth
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
A review of 20 years' experience with the Novopen (R) family of insulin injection devices
Jorn Rex et al.
CLINICAL DRUG INVESTIGATION (2006)